Adamas Pharmaceuticals
Latest round
- Series D
Last raised
- Oct 2009
Total raised
- $67M
Investors
- 4
About Adamas Pharmaceuticals
Founded in 2002 and based in California, US, Adamas Pharmaceuticals, Inc. develops small-molecule-advantaged therapeutics to treat neurological and infectious diseases., a portfolio company of Abingworth, New Enterprise Associates, and OrbiMed Advisors, agreed to acquire Adamas Pharmaceuticals, Inc. from Aeris Capital, DAG Ventures, Mohr Davidow Ventures, and Northgate Capital for approximately USD 450 million. Adamas Pharmaceuticals, Inc. offers GOCOVRI, an extended-release capsule medication for treating levodopa-induced dyskinesia in Parkinson's patients. OSMOLEX ER, another extended-release medication containing amantadine, is used for treating Parkinson's disease and drug-induced side effects. The company also offers Namzaric, a medication combining memantine and donepezil for Alzheimer's disease.
Who invested in Adamas Pharmaceuticals
4 investors across 3 rounds
See all investors in Adamas Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Adamas Pharmaceuticals
Who invested in Adamas Pharmaceuticals?
Adamas Pharmaceuticals has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adamas Pharmaceuticals raised?
Adamas Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Adamas Pharmaceuticals last raise money?
Adamas Pharmaceuticals's most recent round on record is a Series D, in Oct 2009.
What does Adamas Pharmaceuticals do?
Founded in 2002 and based in California, US, Adamas Pharmaceuticals, Inc.
Where is Adamas Pharmaceuticals headquartered?
Adamas Pharmaceuticals is headquartered in Emeryville, US.
Which VCs invest in companies like Adamas Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Adamas Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Adamas Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.